Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ifosfamide and Aprepitant Interaction in Soft Tissue Sarcoma
NCT03514381Phase 4Completed
- Sponsor
- Institut Claudius Regaud
- Start
- May 2018
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aprepitant in soft tissue sarcoma (STS), sponsored by Institut Claudius Regaud. Started May 2018; status: completed.
02
Drugs
aprepitant
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT03514381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03514381.